Search Results - "Giama, Nasra"

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation by Kisiel, John B., Dukek, Brian A., V.S.R. Kanipakam, Reddappa, Ghoz, Hassan M., Yab, Tracy C., Berger, Calise K., Taylor, William R., Foote, Patrick H., Giama, Nasra H., Onyirioha, Kristeen, Abdallah, Mohamed A., Burger, Kelli N., Slettedahl, Seth W., Mahoney, Douglas W., Smyrk, Thomas C., Lewis, Jason T., Giakoumopoulos, Maria, Allawi, Hatim T., Lidgard, Graham P., Roberts, Lewis R., Ahlquist, David A.

“…Early detection improves hepatocellular carcinoma (HCC) outcomes, but better noninvasive surveillance tools are needed. We aimed to identify and validate…”
Get full text

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score by Yang, Ju Dong, Addissie, Benyam D, Mara, Kristin C, Harmsen, William S, Dai, Jianliang, Zhang, Ning, Wongjarupong, Nicha, Ali, Hawa M, Ali, Hamdi A, Hassan, Fatima A, Lavu, Sravanthi, Cvinar, Jessica L, Giama, Nasra H, Moser, Catherine D, Miyabe, Katsuyuki, Allotey, Loretta K, Algeciras-Schimnich, Alicia, Theobald, J Paul, Ward, Melissa M, Nguyen, Mindie H, Befeler, Alex S, Reddy, K Rajender, Schwartz, Myron, Harnois, Denise M, Yamada, Hiroyuki, Srivastava, Sudhir, Rinaudo, Jo Ann, Gores, Gregory J, Feng, Ziding, Marrero, Jorge A, Roberts, Lewis R

“…The GALAD score is a serum biomarker-based model that predicts the probability of having hepatocellular carcinoma (HCC) in patients with chronic liver disease…”
Get full text

Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma by Lavu, Sravanthi, Therneau, Terry M., Harmsen, William S., Mara, Kristin C., Wongjarupong, Nicha, Hassan, Mohamed, Ali, Hamdi A., Antwi, Samuel, Giama, Nasra H., Miyabe, Katsuyuki, Roberts, Lewis R.

“…Background and Aims Statins have been proven to be cytotoxic to human cholangiocarcinoma cells by inhibiting cell division and inducing apoptosis. We aimed to…”
Get full text

Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation by Chaiteerakij, Roongruedee, Zhang, Xiaodan, Addissie, Benyam D., Mohamed, Essa A., Harmsen, William S., Theobald, Paul J., Peters, Brian E., Balsanek, Joseph G., Ward, Melissa M., Giama, Nasra H., Moser, Catherine D., Oseini, Abdul M., Umeda, Naoki, Venkatesh, Sudhakar, Harnois, Denise M., Charlton, Michael R., Yamada, Hiroyuki, Satomura, Shinji, Algeciras‐Schimnich, Alicia, Snyder, Melissa R., Therneau, Terry M., Roberts, Lewis R.

“…Growing evidence suggests that pretransplant alpha‐fetoprotein (AFP) predicts outcomes of hepatocellular carcinoma (HCC) patients treated with liver…”
Get full text

Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma by Estevez, Jacqueline, Yang, Ju Dong, Leong, Jennifer, Nguyen, Pauline, Giama, Nasra H, Zhang, Ning, Ali, Hamdi A, Lee, Mei-Hsuan, Cheung, Ramsey, Roberts, Lewis, Schwartz, Myron, Nguyen, Mindie H

“…African-Americans (AA) have a higher incidence of hepatocellular carcinoma (HCC) and lower survival. We characterized survival rates and clinical features…”
Get full text

Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma by Yang, Ju Dong, Campion, Michael B., Liu, Minetta C., Chaiteerakij, Roongruedee, Giama, Nasra H., Ahmed Mohammed, Hager, Zhang, Xiaodan, Hu, Chunling, Campion, Victoria L., Jen, Jin, Venkatesh, Sudhakar K., Halling, Kevin C., Kipp, Benjamin R., Roberts, Lewis R.

“…Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are…”
Get full text

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma by Miyabe, Katsuyuki, Chandrasekhara, Vinay, Wongjarupong, Nicha, Chen, Jun, Yang, Lu, Johnson, Stephen, Chia, Nicholas, Walther-Antonio, Marina, Yao, Janet Z, Harrington, Sean C, Nordyke, Cynthia K, Eaton, John E, Gossard, Andrea A, Oli, Sharad, Ali, Hamdi A, Lavu, Sravanthi, Giama, Nasra H, Hassan, Fatima A, Ali, Hawa M, Enders, Felicity T, Ilyas, Sumera I, Gores, Gregory J, Topazian, Mark D, Kashyap, Purna C, Roberts, Lewis R

“…Primary sclerosing cholangitis (PSC) is a major risk factor for cholangiocarcinoma (CCA). We investigated biliary and fecal microbiota to determine whether…”
Get full text

Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA by Hlady, Ryan A, Zhao, Xia, Pan, Xiaoyu, Yang, Ju Dong, Ahmed, Fowsiyo, Antwi, Samuel O, Giama, Nasra H, Patel, Tushar, Roberts, Lewis R, Liu, Chen, Robertson, Keith D

“…Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is growing in incidence but treatment options remain limited, particularly for late…”
Get full text

High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence by Mohamed, Essa A, Giama, Nasra H, Abdalla, Abubaker O, Shaleh, Hassan M, Oseini, Abdul M, Ali, Hamdi A, Ahmed, Fowsiyo, Taha, Wesam, Ahmed Mohammed, Hager, Cvinar, Jessica, Waaeys, Ibrahim A, Ali, Hawa, Allotey, Loretta K, Ali, Abdiwahab O, Mohamed, Safra A, Harmsen, William S, Ahmmad, Eimad M, Bajwa, Numra A, Afgarshe, Mohamud D, Shire, Abdirashid M, Balls-Berry, Joyce E, Roberts, Lewis R

“…Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are known risk factors for liver disease, cirrhosis and hepatocellular carcinoma (HCC)…”
Get full text

BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort study by Wongjarupong, Nicha, Negron-Ocasio, Gabriela M., Mara, Kristin C., Prasai, Kritika, Abdallah, Mohamed A., Ahn, Keun Soo, Yang, Ju Dong, Addissie, Benyam D., Giama, Nasra H., Harmsen, William S., Therneau, Terry M., Roberts, Lewis R.

“…The BALAD score and BALAD-2 class derived from bilirubin, albumin, AFP, AFP-L3, and des-gamma-carboxyprothrombin (DCP) are effective in predicting mortality in…”
Get full text

SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma by Martini, Andrea, Prasai, Kritika, Zemla, Tyler J, Ahmed, Fowsiyo Y, Elnagar, Mamoun B, Giama, Nasra H, Guzzardo, Vincenza, Biasiolo, Alessandra, Fassan, Matteo, Yin, Jun, Pontisso, Patrizia, Roberts, Lewis R

“…Cholangiocarcinoma (CCA), the second most common primary liver tumor, is associated with a dismal outcome, and useful prognostic markers are not currently…”
Get full text

Metformin does not improve survival in patients with hepatocellular carcinoma by Bhat, Mamatha, Chaiteerakij, Roongruedee, Harmsen, William S, Schleck, Cathy D, Yang, Ju Dong, Giama, Nasra H, Therneau, Terry M, Gores, Gregory J, Roberts, Lewis R

“…AIM:To assess whether metformin,which has a chemopreventive effect in chronic liver disease,has any chemotherapeutic effect in hepatocellular…”
Get full text

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma by Jun, Tomi W., Yeh, Ming‐Lun, Yang, Ju Dong, Chen, Vincent L., Nguyen, Pauline, Giama, Nasra H., Huang, Chung‐Feng, Hsing, Ann W., Dai, Chia‐Yen, Huang, Jee‐Fu, Chuang, Wan‐Long, Roberts, Lewis R., Yu, Ming‐Lung, Nguyen, Mindie H.

“…Background & Aims Although hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain major risk factors for hepatocellular carcinoma (HCC),…”
Get full text

Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models by Wongjarupong, Nicha, Negron-Ocasio, Gabriela M, Chaiteerakij, Roongruedee, Addissie, Benyam D, Mohamed, Essa A, Mara, Kristin C, Harmsen, William S, Theobald, J Paul, Peters, Brian E, Balsanek, Joseph G, Ward, Melissa M, Giama, Nasra H, Venkatesh, Sudhakar K, Harnois, Denise M, Charlton, Michael R, Yamada, Hiroyuki, Algeciras-Schimnich, Alicia, Snyder, Melissa R, Therneau, Terry M, Roberts, Lewis R

“…To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma (HCC) patients after liver…”
Get full text

A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection by Li, Ying, Chaiteerakij, Roongruedee, Kwon, Jung Hyun, Jang, Jeong Won, Lee, Hae Lim, Cha, Stephen, Ding, Xi Wei, Thongprayoon, Charat, Ha, Fu Shuang, Nie, Cai Yun, Zhang, Qian, Yang, Zhen, Giama, Nasra H., Roberts, Lewis R., Han, Tao

“…Infection is a common cause of death in patients with advanced cirrhosis. We aimed to develop a predictive model in Child-Turcotte-Pugh (CTP) class C…”
Get full text

Sa1864 Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients With Liver Cirrhosis by Ahmed Mohammed, Hager F, Giama, Nasra H, Roberts, Lewis R

Get full text

Sa1858 Undiagnosed Nonalcoholic Steatohepatitis (NASH) Is Responsible for a Significant Proportion of Cryptogenic Hepatocellular Carcinoma (HCC) by Dhanasekaran, Renumathy, Rizvi, Zaheer H, Giama, Nasra H, Roberts, Lewis R

Get full text

Sa1128 Hepatocellular Carcinoma Characteristics and Outcomes among Somali Immigrants vs. Non-Hispanic Whites by Ali, Hawa, Giama, Nasra H, Mohammed, Hager F. Ahmed, Mohamed, Essa A, Yang, Ju Dong, Oseini, Abdul, Shire, Abdirashid, Roberts, Lewis

Get full text

Identification of fucosylated Fetuin‐A as a potential biomarker for cholangiocarcinoma by Betesh, Lucy, Comunale, Mary Ann, Wang, Mengjun, Liang, Hongyan, Hafner, Julie, Karabudak, Aykan, Giama, Nasra H., Moser, Catherine D., Miyoshi, Eiji, Roberts, Lewis R., Block, Timothy M., Mehta, Anand

“…Purpose Cholangiocarcinoma (CCA) is a malignancy of the bile ducts. The purpose of this discovery study was to identify effective serum markers for…”
Get full text

Black Patients with Hepatocellular Carcinoma (HCC) Diagnosed After 2010 have Worse Long-Term Survival Than White Patients by Estevez, Jacqueline, Yang, Ju Dong, Leong, Jennifer, Nguyen, Pauline, Giama, Nasra H, Schwartz, Myron, Roberts, Lewis R, Nguyen, Mindie H

Get full text